Brought to you by:
Care for intermittent claudication considered ‘inappropriate’ found to be common, putting patients at ‘increased’ risk
In a multi-institutional cohort of patients with intermittent claudication (IC), care deemed inappropriate, or where the risk outweighs the benefit, by the SVS appropriate use criteria (AUC) for the management of IC was “common” and associated with increased risk of…
PERT, AI and the rise of thrombectomy devices: ‘PERT leads to more advanced thrombectomy removal therapies, lower hospital stays’
The increasing sophistication of the device space for the treatment of pulmonary embolism (PE) aligned with advances in the deployment of pulmonary embolism response teams (PERTs) are among factors leading to notable improvements in care, according to leading vascular surgeon…
Early-bird deadline for SAVS 2026 approaches
The early-bird deadline for registration at the 2026 Southern Association for Vascular Surgery (SAVS) annual meeting in Paradise Island, the Bahamas (Jan. 21–24) falls tomorrow (Dec. 13). SAVS organizers are encouraging those planning to attend to sign up before the…
Deadline extended for SCVS Young Surgeons Program
The application deadline for the Society for Clinical Vascular Surgery (SCVS) 2026 Young Vascular Surgeons Program has been extended until midnight Eastern Time on Sunday (Dec. 14). The program will take place as part of the 2026 SCVS Annual Symposium…
Medtronic announces first commercial use of Liberant thrombectomy system
Medtronic has announced the first commercial use of its Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems. Medtronic notes that Liberant expands the…
Philips expands commercial availability of LumiGuide imaging system
Philips has announced the expanded commercial availability of LumiGuide 3D device guidance—the much-heralded first real-time artificial intelligence (AI)-enabled light-based navigation solution for image-guided therapy—across Europe and the U.S. LumiGuide integrates with Philips’ Azurion platform, which is designed to drive procedural…
NIH-funded WARRIORS trial advances toward launch
The National Institutes of Health (NIH) has approved funding for the WARRIORS international randomized trial comparing endovascular aneurysm repair (EVAR) with watchful waiting in women with small abdominal aortic aneurysms (AAAs) measuring 4–5.5 centimeters. In the United States, the trial…
SVS smoking cessation initiative aligns with national cancer society effort to help efforts aimed at curbing the habit
Vascular specialists have been intensifying efforts to combat tobacco use through the Society for Vascular Surgery Patient Safety Organization (SVS PSO), which is leading a targeted campaign to help patients quit smoking and reduce their risk of vascular disease. The…
Meta-analysis: Drug-coated devices show comparable aggregate outcomes to non-drug-coated devices in CLTI
Drug-coated balloon (DCB) angioplasty appears to offer similar benefits as plain old balloon angioplasty (POBA), with or without stenting, for patients with chronic limb-threatening ischemia (CLTI) who are undergoing endovascular femoropopliteal segment lower extremity revascularization, according to new meta-analysis data…
‘Vascular surgery is leading the way’: Neurodivergence in care
“We are the first major U.S.-based surgical society to present this topic to our membership. Once again, vascular surgery is leading the way,” said Carlos Pineda, MD, a member of the Society for Vascular Surgery (SVS) Cultural Competency Committee (CCC),…